Vik Kini
Analyst · Wolfe Research.
Probably backwards, frankly. So to start with your second question, they're kind of distinct. So yes, we are seeing inflation, but we're still very much committed to the 100 billion dollars of total synergies of which obviously, the agenda procurement direct material component comprises a big, big component. So it's no different than how we've messaged it before, even coming into the year, we were seeing, I would say $100 million expectation of synergies, and frankly, a smaller degree of inflation, clearly, inflationary pressures have probably grown a bit. But, those two numbers are somewhat distinct. And that's the way we're kind of managing it. Clearly our teams have done a really great job, when you think about the procurement and supply chain organizations, they've now really, I'd say, you know, been able to, I would say, use IRX and use a lot of our internal processes to be able to balance, as their attention between both synergy delivery, as well as managing a lot of the supply chain and logistics constraints that, frankly, the general markets have seen. So I think right now, we're extremely pleased, are we seeing any dramatic push out of savings, or anything of that nature compared to our original expectations? No, not in any material manner? I think for us, what we've been seeing here has probably given us a bit of a acceleration in the context of looking at more I2V initiatives as a means to mitigate. So, like we said, we're not immune to what's going on. But I think that right now, we're kind of keeping that synergy equation quite balanced to what we originally thought. And also opening, I'd say, the team up to, frankly, looking at more I2V initiatives and things like that as cost mitigants.